fig10

Figure 10. Immunotherapy response and survival analysis of MOMLS. (A) Distribution of MOMLS across various immune therapy response groups; (B) TIDE algorithm predictions of immune therapy responses for high and low MOMLS groups; (C) Subclass mapping algorithm predictions of immune therapy responses between high and low MOMLS groups; (D) KM curves for high and low MOMLS groups in the GSE78220 immune dataset; (E) Distribution of MOMLS in different immune therapy datasets, including GSE91061. MOMLS: Multi-omics-driven machine learning signature; TIDE: tumor immune dysfunction and exclusion; KM: Kaplan-Meier; CTLA-4: cytotoxic T-lymphocyte-associated protein 4; PD-1: programmed cell death protein 1.